Identification of and Management Approaches for the High-Risk Patient

American Journal of Cardiology

Volumn 98, Issue 12 SUPPL. 1, 2006, Pages

  Bhatt, Deepak L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; INSULIN;

ARTICLE; ATHEROSCLEROSIS; ATHEROTHROMBOSIS; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

ASPIRIN; CLINICAL TRIALS; CORONARY ARTERY BYPASS; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; THROMBOEMBOLISM; TICLOPIDINE;

EID: 33845311200     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.09.021     Document Type: Article

References (16)

1. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
2. Arbustini E., Dal Bello B., Morbini P., Burke A.P., Bocciarelli M., Specchia G., and Virmani R. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 82 (1999) 269-272
3. Lichtman J.H., Krumholz H.M., Wang Y., Radford M.J., and Brass L.M. Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project. Circulation 105 (2002) 1082-1087
4. Coccheri S. Distribution of symptomatic atherothrombosis and influence of atherosclerotic disease burden on risk of secondary ischaemic events: results from CAPRIE. Eur Heart J 19 suppl 1 (1998) 1268
5. Hankey G.J., Jamrozik K., Broadhurst R.J., Forbes S., Burvill P.W., Anderson C.S., and Stewart-Wynne E.G. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 31 (2000) 2080-2086
6. Ouriel K. Peripheral arterial disease. Lancet 358 (2001) 1257-1264
7. Bhatt D.L., Chew D.P., Hirsch A.T., Ringleb P.A., Hacke W., and Topol E.J. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 103 (2001) 363-368
8. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., and Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
9. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
10. Kannel W.B. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 18 (1995) 181-196
11. Bhatt D.L. Aspirin resistance: more than just a laboratory curiosity. J Am Coll Cardiol 43 (2004) 1127-1129
12. Chew D.P., Bhatt D.L., Robbins M.A., Penn M.S., Schneider J.P., Lauer M.S., Topol E.J., and Ellis S.G. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104 (2001) 992-927.
13. Mills R., and Bhatt D.L. The yin and yang of arterial inflammation. J Am Coll Cardiol 44 (2004) 50-52
14. Bhatt D.L., Marso S.P., Hirsch A.T., Ringleb P.A., Hacke W., and Topol E.J. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 90 (2002) 625-628
15. Bhatt D.L., and Topol E.J. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J 148 (2004) 263-268
16. Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., Cacoub P., Cohen E.A., Creager M.A., Easton J.D., et al., CHARISMA Investigators. A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J 150 (2005) 401.e1-401.e7